title: Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA.
abstract: Ablative therapies have been utilized with increasing frequency for the treatment of Barrett's esophagus with and without dysplasia. Multiple modalities are available for topical ablation of the esophagus, but radiofrequency ablation (RFA) remains the most commonly used. There have been significant advances in technique since the introduction of RFA. The aim of this paper is to review the indications, techniques, outcomes, and most common complications following esophageal ablation with RFA.
authors.affiliation: Roswell Park Cancer Institute Elm & Carlton Streets, Buffalo, NY 14263, USA.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Tuttle
authors.affiliation: Roswell Park Cancer Institute Elm & Carlton Streets, Buffalo, NY 14263, USA.
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Nurkin
authors.affiliation: Roswell Park Cancer Institute Elm & Carlton Streets, Buffalo, NY 14263, USA.
authors.forename: Steven N
authors.initials: SN
authors.lastname: Hochwald
mesh_terms: D057908:Argon Plasma Coagulation; D001471:Barrett Esophagus / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D017679:Cryotherapy; D004724:Endoscopy; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D010778:Photochemotherapy